Impedimed Ltd (ASX:IPD) Share Price

Company Profile

Business description
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognizes revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.
Contact
50 Parker Court
Unit 1
PinkenbaQLD4008
AUS
T: +61 738603700
https://www.impedimed.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 June 2026
Employees
76

Recommended

Markets appear underwhelmed by recent sales growth, however, our kingmaker thesis is intact.

Roy Van Keulen | 27 August 2025

Woolworths have had a soft start to a challenging year, but Morningstar analyst believes it will eventually catch up to its main competitor.

Johannes Faul, CFA | 27 August 2025

Opportunities arise when the market overreacts, and good quality companies are mispriced.

Shani Jayamanne | 27 August 2025

Index	Last price	Change	% Change
All Ordinaries	9,241.10	0.50	-0.01%
CAC 40	7,762.60	18.67	0.24%
DAX 40	24,039.92	6.29	-0.03%
Dow JONES (US)	45,603.07	37.84	0.08%
FTSE 100	9,216.82	38.68	-0.42%
HKSE	24,998.82	202.94	-0.81%
NASDAQ	21,722.52	132.38	0.61%
Nikkei 225	42,828.79	308.52	0.73%
NZX 50 Index	12,903.08	41.24	0.32%
S&P 500	6,501.67	20.27	0.31%
S&P/ASX 200	8,980.00	9.50	0.11%
SSE Composite Index	3,843.60	43.25	1.14%